Sign inJoin waitlistJoin the waitlist

Dustin Fraidenburg

Associate Professor of Medicine · University of Illinois College of Medicine at Chicago

Credentials: · · · ·

History

University of Illinois College of Medicine at Chicago
Present

Pulmonary Disease and Critical Care Medicine
University of Illinois College of Medicine at Chicago
2012–2015
Internal Medicine
2009–2012
Wayne State University School of Medicine
2005–2009

Research

Inhaled Antibiotics for Gram-Negative Respiratory Infections
Review · Clinical Microbiology Reviews · 2016 · 100 citations
Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension
American Journal of Respiratory Cell and Molecular Biology · 2015 · 99 citations
Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension
American Journal of Physiology-Lung Cellular and Molecular Physiology · 2015 · 87 citations

JG
Janae Gonzales
5 papers · 5 as a fellow
Roberto Machado
4 papers
Kelsey Holbert
3 papers · 3 as a resident
Aleezay Asghar
1 paper · 1 as a fellow
Ankit Desai
1 paper
AU
Ashar Usmani
1 paper
Benjamin Follman
1 paper · 1 as a fellow
BL
Benjamin Levin
1 paper
Caroline Fernandes
1 paper
Christen Vagts
1 paper · 1 as a fellow
Christian Ascoli
1 paper
David Allison
1 paper

Grants

Diverse Effects of Hemin on the Endothelium Contribute to Pulmonary Complications of Sickle Cell Disease
National Heart, Lung, and Blood Institute · R56
Contact PI · $607.5K · University of Illinois at Chicago
2024–2026
The Role of NFATc3 in Altered Hypoxic Pulmonary Vasoconstriction During Acute Lung Injury
National Heart, Lung, and Blood Institute · K08
Contact PI · $975.2K · University of Illinois at Chicago
2016–2022

Clinical trials

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Site PI · Recruiting
Tempus AI
2025–2028
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Site PI · Recruiting · Phase 3
United Therapeutics
2023–2027